# BAVENCIO

NDC: 44087-3535
Generic name: avelumab
Labeler / Manufacturer: EMD Serono, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20170323

FDA application: BLA761049

## Active ingredients

- AVELUMAB: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"44087-3535"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=44087-3535
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cd725a1-2fa4-408a-a651-57a7b84b2118